NCT05067621: Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
- State
- Under way
- Phase
- Phase 2
- People
- 60 taking part
- Started
- 17 Jul 2023
- Primary completion
- Dec 2026
- Arms
- Receive treatment
- Results
- None posted
- 5 Oct 2021: Trial registered
- 17 Jul 2023: Trial started